• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗老年人的结核病。

Treating tuberculosis in older adults.

作者信息

Zanni Guido R, Wick Jeannette Y

机构信息

The Consultant Pharmarcist, USA.

出版信息

Consult Pharm. 2008 Nov;23(11):844-6, 851-8. doi: 10.4140/tcp.n.2008.844.

DOI:10.4140/tcp.n.2008.844
PMID:19072010
Abstract

Every second, someone becomes infected with tuberculosis (TB) someplace on Earth. Mycobacterium tuberculosis generally affects the lungs, but can attack any organ. TB occurs along a continuum, and infected individuals may have latent or active TB. In the United States, public health efforts between 1953 and the early 1980s successfully reduced the number of cases. The number began to grow in the 1980s, and several causes were implicated. In the last few years, the number of active TB cases has declined significantly, but drug-resistant TB has become a growing concern. The elderly are at high risk for TB, especially if they are long-term care residents.

摘要

每一秒,地球上都会有某人在某个地方感染结核病(TB)。结核分枝杆菌通常侵袭肺部,但也可能攻击任何器官。结核病呈连续变化过程,受感染个体可能患有潜伏性或活动性结核病。在美国,1953年至20世纪80年代初的公共卫生努力成功减少了病例数量。该数量在20世纪80年代开始增长,涉及多种原因。在过去几年中,活动性结核病病例数量显著下降,但耐多药结核病已成为日益令人担忧的问题。老年人患结核病的风险很高,尤其是那些长期护理机构的居民。

相似文献

1
Treating tuberculosis in older adults.治疗老年人的结核病。
Consult Pharm. 2008 Nov;23(11):844-6, 851-8. doi: 10.4140/tcp.n.2008.844.
2
Resistance to anti-tuberculosis medications in the Horn of Africa.非洲之角的抗结核药物耐药性。
Int J Tuberc Lung Dis. 2011 Mar;15(3):414-6.
3
Trench warfare in a battle with TB.与结核病斗争中的堑壕战。
Science. 2008 Jul 18;321(5887):362-4. doi: 10.1126/science.321.5887.362.
4
Mechanisms of drug resistance in Mycobacterium tuberculosis.结核分枝杆菌耐药机制。
Int J Tuberc Lung Dis. 2009 Nov;13(11):1320-30.
5
Global clinical trials for the treatment of TB with thioridazine.使用硫利达嗪治疗结核病的全球临床试验。
Recent Pat Antiinfect Drug Discov. 2011 May;6(2):99-103. doi: 10.2174/157489111796064533.
6
Tuberculosis; opportunities for treatment optimization.结核病;优化治疗的机遇
Curr Pharm Des. 2011;17(27):2852. doi: 10.2174/138161211797470219.
7
Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance.结核分枝杆菌治疗新药发现趋势及耐药性一瞥
Tuberculosis (Edinb). 2018 Mar;109:17-27. doi: 10.1016/j.tube.2017.12.002. Epub 2017 Dec 9.
8
State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.耐药结核病的最新进展系列:是时候保护氟喹诺酮类药物了。
Int J Tuberc Lung Dis. 2009 Nov;13(11):1319.
9
Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity.香豆素杂合衍生物作为有前途的抗结核治疗先导物:为展现抗结核活性进行结构设计的最新进展和关键方面。
Tuberculosis (Edinb). 2021 Mar;127:102050. doi: 10.1016/j.tube.2020.102050. Epub 2021 Jan 6.
10
[Management of multidrug-resistant tuberculosis].[耐多药结核病的管理]
Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):130-9. doi: 10.1016/j.pneumo.2014.05.001. Epub 2014 Aug 19.